However, the effects of miR-17-92 on breast carcinoma biology are pleiotropic [26] and might also include indirect effects on angiogenesis or metastatic potential [27], potentially related to extracellular matrix changes [28], complex modulation of ER pathways [29] or regulation of tumor-suppressor genes [30,31]. Here, ESR1 is linked to breast carcinoma.